AMACR and prostate carcinoma: In the case group expressing AMACR protein, individuals with the AG or GG genotype of rs2278008 showed a decreased prostate cancer risk compared to those with the AA genotype (adjusted OR 0.47; 95% CI, 0.26–0.87, P = 0.017; Table 4 and supplemental figure).